NSCIF - Nanalysis Scientific Corp.
Chart Events
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 0.3231 |
| Open | 0.3790 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.3790 - 0.4032 |
| 52 Week Range | 0.3140 - 1.0100 |
| Volume | |
| Avg. Volume | 31,529 |
| Market Cap | 46.967M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0500 |
| Earnings Date | Aug 23, 2023 - Aug 28, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
PR NewswireNanalysis Reports First Quarter 2023 Results
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its first quarter results ending March 31, 2023. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. The second call for European investors at 8:30am ET, tomorrow, Friday, May 26 has been cancelled since
CNW GroupNanalysis Announces First Quarter 2023 Conference Call
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications announces that on Thursday, May 25th, 2023, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending March 31, 2023.
CNW GroupNanalysis Scientific Corp. Announces Closing of Second Tranche to Fully Complete its $4,128,700 Offering
Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce, further to its news releases dated April 21, 2023, April 26, 2023 and May 1, 2023, it has successfully closed the second and final tranche (the "Second Tranche") of its $4,128,700 non-brokered private placement (the "Offering").
PR NewswireNanalysis Scientific Corp. Announces Upsize to Private Placement of Units
Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that due to strong investor demand, the Company has increased the size of its previously announced non-brokered private placement of units of the Company (the "Units"). The Company will now issue up to 6,881,167 Units at a price of $0.60 per Unit for aggregate gross proceeds of up to $4,128,700 (the "Offering").
PR NewswireNanalysis Reports Fourth Quarter and Full Year 2022 Results
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for industrial and research applications, releases its fourth quarter and full year results ending December 31, 2022. Chief Executive Officer, Sean Krakiwsky and Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Friday, April 28th.
CNW GroupNanalysis Scientific Corp. Announces Closing of First Tranche of Private Placement
Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce it has closed the first tranche of its previously announced non-brokered private placement on April 21, 2023 (the "Offering").The Company has issued a total of 3,738,667 units ("Units") at a price of $0.60 per Unit for gross proceeds of $2,243,200. Each Unit consisted of one common share in the capital of the Company (a "Common Share") and one Common Share purchase warrant (a "Wa
PR NewswireNanalysis Scientific Corp. Announces $3.5 Million Private Placement
Nanalysis Scientific Corp. ("Nanalysis" or the "Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1) is pleased to announce that it intends to complete a non-brokered private placement (the "Offering") of up to 5,833,333 units of the Company (the "Units") at a price of $0.60 per Unit for aggregate gross proceeds of up to $3,500,000.
PR NewswireNanalysis and QUAD Systems Launch Full 400MHz High Field System
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications announces that QUAD Systems will debuting the new 400MHz High Field NMR system in collaboration with Nanalysis at the Experimental Nuclear Magnetic Resonance conference (ENC 2023) at the Asilomar Hotel & Conference Center, Pacific Grove, California on April 16-20th. Nanalysis collaborated and provides the console as one of
PR NewswireNanalysis Announces Fourth Quarter and Full Year 2022 Conference Call
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications announces that on Thursday, April 27th, 2023, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter and year ending December 31, 2022.
CNW GroupNanalysis Scientific Corp. to Participate in the Industrial Tech Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that Company CEO Sean Krakiwsky has been invited to present on the panel "Growing Opportunities in Industrial & Medical Markets" at the Industrial Tech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, March 21st 2023 at 1:00 p.m. ET.
PR NewswireNanalysis Scientific Corp. Announces Grant of Stock Options
Nanalysis Scientific Corp. (TSXV:NSCI, OTCQX:NSCIF, FRA:1N1) ("Nanalysis" or the "Company") announces that the Company's Board of Directors has granted 335,000 stock options to Directors and Officers of the Company, pursuant to the Company's stock option plan. Each option is exercisable to purchase one common share in the capital of the Company at $1.10 per share for a period of five years from the date of issuance. The options vest as to one-third on each of the 12 month, 24 month, and 36 month
PR NewswireNanalysis Announces Appointment of Randall McRae as CFO
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces the appointment of Randall McRae to Chief Financial Officer.
PR NewswireNanalysis Reports Third Quarter 2022 Results
Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its second quarter results ending September 30, 2022. Chief Executive Officer, Sean Krakiwsky and Interim Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Wednesday, November
PR NewswireNanalysis Announces Third Quarter 2022 Conference Call
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1, a leader in portable NMR machines and MRI technology for healthcare and industrial applications announces that on Tuesday, November 29th, 2022, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Interim Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter ending September 30, 2022.
PR NewswireNanalysis Provides Corporate Update
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, provides a corporate update on operations.
- Newsfile
Nanalysis to Present at LD Micro Main Event XV Investor Conference Presentation is Tuesday, Oct. 25th at 2:00pm PT
Calgary, Alberta--(Newsfile Corp. - October 18, 2022) - Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FSE: 1N1) ("the Company"), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces that Sean Krakiwsky, Founder and CEO of Nanalysis will present at LD Micro's Main Event XV. LD Micro PresentationNanalysis CEO Sean Krakiwsky will be presenting at the LD Micro Conference in Los Angeles on Tuesday, Oct. 25th at ...
CNW GroupNanalysis Reports Second Quarter 2022 Results
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, releases its second quarter results ending June 30, 2022. Chief Executive Officer, Sean Krakiwsky and Interim Chief Financial Officer, Randall McRae will host a conference call at 5 P.M. Eastern Time today to discuss the results. A second call will be held for European investors at 8:30am ET on Friday, August 26th. All in
PR NewswireNanalysis Announces Second Quarter 2022 Conference Call
Nanalysis Scientific Corp. ("the Company", (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications announces that on Thursday, August 25, 2022, the Company will put out a press release and Chief Executive Officer Sean Krakiwsky and Interim Chief Financial Officer Randall McRae will host a conference call at 5:00 P.M. Eastern Time to discuss the results for the quarter June 30, 2022.
PR NewswireNanalysis Scientific Corp. Announces Management Transitions
Nanalysis Scientific Corp. (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1) ("Nanalysis" or the "Company") announces that the current CFO, Luke Caplette, is stepping down as CFO, but will remain with the Company as a part-time consultant to assist the transition to a new CFO. The Company is pleased that its Corporate Controller, Randall McRae, has been appointed interim-CFO.
Simply Wall St.Is Nanalysis Scientific (CVE:NSCI) A Risky Investment?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
PR NewswireNanalysis Announces Results of AGM and Appointment of New Director
Nanalysis Scientific Corp. ("the Company", ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, is pleased to report that all proposed resolutions were approved at the Company's Annual General and Special Meeting of shareholders held on June 22, 2022 (the "Meeting"). The number of directors was set at 7 and all director nominees, as listed in the Management Information Circular dated May 20, 2022 (th
GlobeNewswireOTCQX Best 50 Virtual Investor Conference: Now Available for On-Demand Viewing
NEW YORK, June 17, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 16th OTCQX Best 50 Virtual Investor Conference are now available for on-demand viewing. REGISTER NOW OR LOGIN AT: https://bit.ly/39ueG8gThe company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Companies are accept
- GlobeNewswire
OTCQX Best 50 Virtual Investor Conference: Company Executives Present June 16th
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.comNEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the upcoming OTCQX Best 50 Companies Virtual Investor Conference to be held on June 16th. Individual investors, institutional investors, advisors, and analysts are invited to attend. The program begins at 9:30 AM ET on Thursday, June 16th. REGISTER NOW
CNW GroupNanalysis Presenting at Upcoming Conferences
Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), a leader in portable NMR machines and MRI technology for healthcare and industrial applications, announces it will be attending the following upcoming conferences.